pyridoxamine dihydrochloride has been researched along with Diabetic Glomerulosclerosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldsmith, DJ; Hajhosseiny, R; Jivraj, N; Khavandi, K; Malik, RA; Mashayekhi, S | 1 |
| Broome, BR; Dwyer, JP; Fox, JW; Greco, BA; Greene, LE; Lewis, JB; Packham, D; Peterson, R; Sika, M; Umanath, K | 1 |
| Breyer, MD; Susztak, K | 1 |
| Atkins, RC; Berl, T; Blumenthal, S; Greene, T; Herskovits, T; Hunsicker, LG; Lewis, EJ; Lewis, JB; Packham, DK; Pohl, MA; Raz, I; Reutens, AT; Rohde, RD; Spitalewiz, S; Yagil, Y; Yerushalmy, Y | 1 |
| Chen, JL; Francis, J | 1 |
2 review(s) available for pyridoxamine dihydrochloride and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Have we reached the limits for the treatment of diabetic nephropathy?
Topics: Animals; Diabetic Nephropathies; Humans; Oleanolic Acid; Pyridoxamine; Renin-Angiotensin System; Vitamin D | 2014 |
Developing Treatments for Chronic Kidney Disease in the 21st Century.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Atrasentan; Benzhydryl Compounds; Canagliflozin; Diabetic Nephropathies; Drug Discovery; Endothelin Receptor Antagonists; Glucosides; Glycosaminoglycans; Humans; Hypoglycemic Agents; Mineralocorticoid Receptor Antagonists; Oleanolic Acid; Oxidative Stress; Pyridoxamine; Pyrrolidines; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors | 2016 |
2 trial(s) available for pyridoxamine dihydrochloride and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Pyridoxamine dihydrochloride in diabetic nephropathy (PIONEER-CSG-17): lessons learned from a pilot study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Antioxidants; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Pilot Projects; Pyridoxamine | 2015 |
Pyridorin in type 2 diabetic nephropathy.
Topics: Aged; Creatinine; Cystatin C; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Proteinuria; Pyridoxal Phosphate; Pyridoxamine | 2012 |
1 other study(ies) available for pyridoxamine dihydrochloride and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Pyridoxamine, advanced glycation inhibition, and diabetic nephropathy.
Topics: Diabetic Nephropathies; Female; Humans; Male; Pyridoxamine | 2012 |